Belgia - nederlandsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

amgen europe b.v. - filgrastim r-met hug-csf - eq. filgrastim 10000000 e/ml - oplossing voor injectie in een voorgevulde spuit - 48 mio u (0,96 mg/ml) - filgrastim r-met hug-csf - filgrastim

Belgia - nederlandsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

amgen europe b.v. - filgrastim r-met hug-csf - eq. filgrastim 10000000 e/ml - oplossing voor injectie in een voorgevulde spuit - 30 mio u (0,6 mg/ml) - filgrastim r-met hug-csf - filgrastim

Sveits - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

teva pharma ag - filgrastimum - soluzione iniettabile in siringhe preriempite - filgrastimum 30 mio. u., acidum aceticum glaciale, polysorbatum 80, natrii hydroxidum, sorbitolum 25.0 mg, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium 0.026 mg. - neutropenia - biotechnologika

Sveits - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

teva pharma ag - filgrastimum - soluzione iniettabile in siringhe preriempite - filgrastimum 48 mio. u., acidum aceticum glaciale, polysorbatum 80, natrii hydroxidum, sorbitolum 40.0 mg, aqua ad iniectabile q.s. ad solutionem pro 0.8 ml corresp. natrium 0.042 mg. - neutropenia - biotechnologika

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

teva pharma ag - filgrastimum - solution injectable en seringue pré-remplie - filgrastimum 30 mio. u., acidum aceticum glaciale, polysorbatum 80, natrii hydroxidum, sorbitolum 25.0 mg, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium 0.026 mg. - la neutropénie - biotechnologika

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

teva pharma ag - filgrastimum - solution injectable en seringue pré-remplie - filgrastimum 48 mio. u., acidum aceticum glaciale, polysorbatum 80, natrii hydroxidum, sorbitolum 40.0 mg, aqua ad iniectabile q.s. ad solutionem pro 0.8 ml corresp. natrium 0.042 mg. - la neutropénie - biotechnologika

Sveits - tysk - Swissmedic (Swiss Agency for Therapeutic Products)

teva pharma ag - filgrastimum - injektionslösung in fertigspritzen - filgrastimum 30 mio. u., acidum aceticum glaciale, polysorbatum 80, natrii hydroxidum, sorbitolum 25.0 mg, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium 0.026 mg. - neutropenie - biotechnologika

Sveits - tysk - Swissmedic (Swiss Agency for Therapeutic Products)

teva pharma ag - filgrastimum - injektionslösung in fertigspritzen - filgrastimum 48 mio. u., acidum aceticum glaciale, polysorbatum 80, natrii hydroxidum, sorbitolum 40.0 mg, aqua ad iniectabile q.s. ad solutionem pro 0.8 ml corresp. natrium 0.042 mg. - neutropenie - biotechnologika

Israel - engelsk - Ministry of Health

kamada ltd, israel - pegfilgrastim - solution for injection - pegfilgrastim 10 mg/ml - pegfilgrastim - reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with cytotoxic chemotherapy, given at intervals of 14 days or more, for malignancy (with the exception of chronic myeloid leukemia and myelodysplastic syndromes).

Portugal - portugisisk - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

amgen europe, b.v. - filgrastim - solução injetável - 48 m.u.i./0.5 ml - filgrastim 96 mu/ml - filgrastim - n/a - duração do tratamento: curta ou média duração